CAY 1
Latest Information Update: 17 Feb 2006
At a glance
- Originator National Institutes of Health (USA); Southern Regional Research Center
- Developer MycoLogics; National Institutes of Health (USA); Southern Regional Research Center
- Class Antifungals; Saponins
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Mycoses
Most Recent Events
- 17 Feb 2006 No development reported - Preclinical for Mycoses in USA (unspecified route)
- 16 Oct 2002 Preclinical trials in Mycoses in USA (unspecified route)
- 18 Apr 2002 No development reported - Preclinical for Mycoses in USA (unspecified route)